Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Geyser Brands Inc. V.GYSR.H

Healthcare Drug Manufacturers - Major Cannabis
Geyser Brands Inc builds health-based hemp CBD consumer product businesses in the Nutraceutical, Cosmetics, Food and Beverage and Pet Sectors. Research and Development investment in Nanofusion, proprietary all-natural nanotechnology, delivers creams, beverages, backed goods and tincture formulations with superior bio-availability and water-solubility.


TSXV:GYSR.H - Post by User

Geyser Brands Inc. > This should be the week
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(57)
•••
Post by Pocketfulofhopeon Sep 09, 2019 8:03am
70 Views
Post# 30107735

This should be the week

This should be the weekLet’s close Solace and get the news flowing. Excited to see this take the next step.  Revenue baby revenue
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities